WIERENGA WENDELL
Insider CIK 1239956 · CYTK Director · CRNX Director · DRMA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CYTK CYTOKINETICS INC | A Award | 2026-10-16 | 2026-10-20 | 97 | $63.92 | $6.2K | 35,660 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 9,730 | $49.13 | $478.0K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 10,350 | $52.67 | $545.1K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 12,500 | $40.29 | $503.6K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 17,500 | $64.68 | $1.13M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 17,500 | $66.71 | $1.17M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 17,500 | $64.77 | $1.13M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 12,500 | $61.77 | $772.1K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 12,500 | $61.76 | $772.0K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 5,925 | $85.00 | $503.6K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 116,146 | $85.00 | $9.87M | 5,925 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 9,730 | $49.13 | $478.0K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 10,350 | $52.67 | $545.1K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 12,500 | $40.29 | $503.6K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 17,500 | $64.68 | $1.13M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 17,500 | $66.71 | $1.17M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 17,500 | $64.77 | $1.13M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 12,500 | $61.77 | $772.1K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 12,500 | $61.76 | $772.0K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 5,925 | $85.00 | $503.6K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 116,146 | $85.00 | $9.87M | 5,925 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2026-07-15 | 2026-07-16 | 75 | $82.62 | $6.2K | 35,563 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2026-06-18 | 2026-06-22 | 9,730 | — | $0 | 9,730 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2026-06-18 | 2026-06-22 | 5,925 | — | $0 | 122,071 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award deriv | 2026-05-27 | 2026-05-27 | 4,301 | — | $0 | 4,301 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2026-05-27 | 2026-05-27 | 2,851 | — | $0 | 35,488 | SEC↗ |
| CYTK CYTOKINETICS INC | M Exercise deriv | 2026-05-05 | 2026-05-05 | 4,032 | — | $0 | 0 | SEC↗ |
| CYTK CYTOKINETICS INC | S Sale | 2026-05-05 | 2026-05-05 | 4,032 | $75.00 | $302.4K | 32,637 | SEC↗ |
| CYTK CYTOKINETICS INC | M Exercise | 2026-05-05 | 2026-05-05 | 4,032 | $12.40 | $50.0K | 36,669 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2026-04-15 | 2026-04-15 | 95 | $65.37 | $6.2K | 32,637 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2026-01-15 | 2026-01-16 | 98 | $63.44 | $6.2K | 32,542 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 2,500 | — | $0 | 2,500 | SEC↗ |
| CYTK CYTOKINETICS INC | M Exercise deriv | 2025-12-22 | 2025-12-23 | 20,000 | — | $0 | 0 | SEC↗ |
| CYTK CYTOKINETICS INC | M Exercise | 2025-12-22 | 2025-12-23 | 20,000 | $7.61 | $152.2K | 52,444 | SEC↗ |
| CYTK CYTOKINETICS INC | S Sale | 2025-12-22 | 2025-12-23 | 20,000 | $66.14 | $1.32M | 32,444 | SEC↗ |
| CYTK CYTOKINETICS INC | M Exercise deriv | 2025-10-27 | 2025-10-27 | 4,375 | — | $0 | 0 | SEC↗ |
| CYTK CYTOKINETICS INC | M Exercise | 2025-10-27 | 2025-10-27 | 4,375 | $10.00 | $43.8K | 36,819 | SEC↗ |
| CYTK CYTOKINETICS INC | S Sale | 2025-10-27 | 2025-10-27 | 4,375 | $58.68 | $256.7K | 32,444 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2025-10-15 | 2025-10-21 | 99 | $62.80 | $6.2K | 32,444 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2025-01-13 | 2025-01-14 | 5,000 | — | $0 | 5,000 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2024-01-04 | 2024-01-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award | 2022-10-06 | 2022-10-07 | 20,654 | — | $0 | 62,398 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award | 2022-07-07 | 2022-07-08 | 18,110 | — | $0 | 41,744 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award | 2022-04-07 | 2022-04-08 | 10,593 | — | $0 | 15,471 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 5,000 | — | $0 | 5,000 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | C Conversion deriv | 2021-08-17 | 2021-08-17 | 55,078 | — | $0 | 0 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | C Conversion | 2021-08-17 | 2021-08-17 | 8,163 | — | $0 | 13,041 | SEC↗ |